4
Views
1
CrossRef citations to date
0
Altmetric
Review

Management of refractory overactive bladder

&
Pages 605-613 | Published online: 10 Jan 2014
 

Abstract

Overactive bladder has significant impact on a patient’s quality of life. Conservative and pharmacologic management are effective in most patients. Whereas treatment options were limited many years ago for patients who failed first-line therapy, there are now multiple minimally invasive options for them. Detrusor injection of botulinum toxin, which is not yet officially approved for the treatment of idiopathic overactive bladder, significantly improves patient’s symptoms and quality of life, and is well tolerated. Two types of neuromodulation are also available: posterior tibial nerve stimulation and sacral nerve stimulation. Promising new medications are in the pipeline. For those who do not respond to the minimally invasive options, augmentation cystoplasty or urinary diversion remain options.

Financial & competing interests disclosure

HB Goldman is a consultant and speaker for Allergan and Medtronic and he is a speaker for Astellas. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.